Accelerating NDA filing through faster carcinogenicity assessment
Drug Discovery World
MAY 10, 2023
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) issues guidelines and develops testing strategies for evaluating carcinogenicity along with other risks such as genotoxicity, immunotoxicity, and reproductive toxicity. In practice, this was typically conducted in rats and mice.
Let's personalize your content